Rishi Arora, MBBS, is a highly experienced cardiologist specializing in heart rhythm disorders, including atrial fibrillation and complex arrhythmias. He provides personalized, evidence-based care using the latest treatments to help patients manage their condition and improve their overall well-being. Dr. Arora is approachable and compassionate, taking time to listen, explain conditions in clear terms, and involve them in decisions about their health.
As an expert in cardiac electrophysiology and leading-edge research, Dr. Arora is at the forefront of developing innovative treatments for atrial fibrillation. His research focuses on understanding the molecular mechanisms behind atrial fibrillation, particularly the role of the autonomic nervous system, inflammation and oxidative injury in heart rhythm disorders. His laboratory has pioneered new gene therapy approaches, showing promising results in reducing atrial fibrillation’s effects.
With more than 100 peer-reviewed publications in top medical journals—including Science, Circulation and Nature Biotechnology—Dr. Arora’s work has significantly advanced the field. In recognition of his contributions, he was inducted into the prestigious American Society for Clinical Investigation in 2020.
Association between high-density mapping of atypical atrial flutter, clinical outcomes and healthcare utilization.
Association between high-density mapping of atypical atrial flutter, clinical outcomes and healthcare utilization. J Cardiovasc Electrophysiol. 2024 Sep; 35(9):1779-1785.
PMID: 38965878
Proteolytic degradation of atrial sarcomere proteins underlies contractile defects in atrial fibrillation.
Proteolytic degradation of atrial sarcomere proteins underlies contractile defects in atrial fibrillation. Am J Physiol Heart Circ Physiol. 2024 08 01; 327(2):H460-H472.
PMID: 38940916
Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmias.
Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmias. J Interv Card Electrophysiol. 2024 Oct; 67(7):1647-1655.
PMID: 38761294
In Vivo Mapping of Myocardial Injury Outside the Infarct Zone: Tissue at an Intermediate Pathological State.
In Vivo Mapping of Myocardial Injury Outside the Infarct Zone: Tissue at an Intermediate Pathological State. J Am Heart Assoc. 2024 May 07; 13(9):e032577.
PMID: 38639350
Use of Atrial Fibrillation Electrograms and T1/T2 Magnetic Resonance Imaging to Define the Progressive Nature of Molecular and Structural Remodeling: A New Paradigm Underlying the Emergence of Persistent Atrial Fibrillation.
Use of Atrial Fibrillation Electrograms and T1/T2 Magnetic Resonance Imaging to Define the Progressive Nature of Molecular and Structural Remodeling: A New Paradigm Underlying the Emergence of Persistent Atrial Fibrillation. J Am Heart Assoc. 2024 Mar 05; 13(5):e032514.
PMID: 37930082
Correlation between high- and low-voltage impedance measurements following subcutaneous implantable cardioverter-defibrillator implantation.
Correlation between high- and low-voltage impedance measurements following subcutaneous implantable cardioverter-defibrillator implantation. Heart Rhythm. 2024 04; 21(4):492-494.
PMID: 38159788
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment.
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment. World J Hepatol. 2023 Feb 27; 15(2):318-320.
PMID: 36926235
Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay.
Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. J Cardiovasc Electrophysiol. 2023 03; 34(3):502-506.
PMID: 36640424
Validation of the SCALE-CryoAF risk model to predict very late return of atrial fibrillation after cryoballoon ablation.
Validation of the SCALE-CryoAF risk model to predict very late return of atrial fibrillation after cryoballoon ablation. J Interv Card Electrophysiol. 2023 Nov; 66(8):1859-1865.
PMID: 36754907
Regions of Highly Recurrent Electrogram Morphology With Low Cycle Length Reflect Substrate for Atrial Fibrillation.
Regions of Highly Recurrent Electrogram Morphology With Low Cycle Length Reflect Substrate for Atrial Fibrillation. JACC Basic Transl Sci. 2023 Jan; 8(1):68-84.
PMID: 36777167